bidmc

: This week on *The Heart of Innovation* Hosted by Interventional Cardiologist Dr. John Philips and Emmy Award Winning Journalist Kym McNicholas, The focus is on groundbreaking treatment for hard-to-treat blood pressure. The featured guest is Interventional Cardiologist Dr Eric Secemsky, Director of Vascular Intervention at BIDMC and Section head of Intervetional Cardiology and Vascular research at the Richard. A. and Susan F. Smith Center for Outcomes Research in Cardiology at BIDMC. Dr. Secemsky delves into the prevalence of high blood pressure, affecting nearly half of American adults, with many being unaware of their condition or facing challenges in consistently accessing or adhering to medications. Shockingly only one in four individuals with high blood pressure have it under control, underscoring the urgency of addressing this public health concern. The discussion highlights the subset of patients facing treatment resistant hypertension, where standard medication prove ineffective or intolerable, posing increased risks of heart of disease, stroke, and cardiovascular complications. Dr. Secemsky introduces the pioneering procedure of renal denervation (RDN), which involves permanently disrupting the nerves, controlling the kidneys' arteries. This innovative approach, developed, offers a potential solution for bringing treatment resistant hypertension back under control, offering hope for patients facing persistent challenges in managing their condition. The episode provides a comprehensive exploration of the groundbreaking RDN procedure, offering valuable insights into a first-of-its kind treatment for high blood pressure. Dr. Secemsky's expertise and the innovative advancements in cardiovascular care showcased in this episode underscore the ongoing pursuit of transformative solutions in the field of interventional cardiology. Tune into * The Heart Of Innovation* for an in-depth discussions on this breakthrough treatment for hypertension and its potential impact on reshaping the landscape of vascular care.

See omnystudio.com/listener for privacy information.

This week on *The Heart of Innovation* Hosted by Interventional Cardiologist Dr. John Philips and Emmy Award Winning Journalist Kym McNicholas, The focus is on groundbreaking treatment for hard-to-treat blood pressure. The featured guest is Interventional Cardiologist Dr Eric Secemsky, Director of Vascular Intervention at BIDMC and Section head of Intervetional Cardiology and Vascular research at the Richard. A. and Susan F. Smith Center for Outcomes Research in Cardiology at BIDMC. Dr. Secemsky delves into the prevalence of high blood pressure, affecting nearly half of American adults, with many being unaware of their condition or facing challenges in consistently accessing or adhering to medications. Shockingly only one in four individuals with high blood pressure have it under control, underscoring the urgency of addressing this public health concern. The discussion highlights the subset of patients facing treatment resistant hypertension, where standard medication prove ineffective or intolerable, posing increased risks of heart of disease, stroke, and cardiovascular complications. Dr. Secemsky introduces the pioneering procedure of renal denervation (RDN), which involves permanently disrupting the nerves, controlling the kidneys' arteries. This innovative approach, developed, offers a potential solution for bringing treatment resistant hypertension back under control, offering hope for patients facing persistent challenges in managing their condition. The episode provides a comprehensive exploration of the groundbreaking RDN procedure, offering valuable insights into a first-of-its kind treatment for high blood pressure. Dr. Secemsky's expertise and the innovative advancements in cardiovascular care showcased in this episode underscore the ongoing pursuit of transformative solutions in the field of interventional cardiology. Tune into * The Heart Of Innovation* for an in-depth discussions on this breakthrough treatment for hypertension and its potential impact on reshaping the landscape of vascular care.

See omnystudio.com/listener for privacy information.

There’s a chance at this point of your life, you might know someone with kidney disease, maybe someone who has needed a kidney transplant — or maybe you even someone who has made the decision to donate their kidney.

March is National Kidney Month. Last week, I introduced you to Kari Kirkland, a living kidney donor who not only made that incredibly courageous decision to donate her kidney to a friendly acquaintance, but who just last week climbed Mt Kilimanjaro to spread awareness, reaching the summit on World Kidney Day. 

This week is the second episode in our two-part series. I speak with Dr Martha Pavlakis, the medical director of kidney and pancreas transplantation at Beth Israel Deaconess Medical Center in Boston, and associate professor of medicine at Harvard Medical School. In just an hour of your life, Dr Pavlakis will help us all understand kidney transplants and donations in a whole new way, as she busts some very common myths about the process that people continue to spread every day.

About: Dr. Martha Pavlakis is the medical director of kidney and pancreas transplantation at Beth Israel Deaconess Medical Center where she has held that position since 1999. She is an associate professor of medicine at Harvard Medical School and the Co-director of the BIDMC Kidney Transplant Fellowship. Dr. Pavlakis has written and spoken extensively about kidney and pancreas transplantation and is the current Chair of the Organ Procurement and Transplantation Network (OPTN) Kidney Committee. She has led the OPTN effort to eliminate the use of race in eGFR formulas used for listing patients for kidney transplantation and the current restorative justice project to award more wait time to Black and African American transplant candidates whose wait time was impacted by the race variable. She also leads the development of a continuous distribution system for kidney transplant allocation. She is a former chair of the education committee for the American Society of Transplantation (AST) and on the IDEAL committee (Inclusion, Diversity, Equity and Access to Life).

Resources:
National Kidney Foundation
Living Donor Assistance
UNOS
National Kidney Registry
OPTN

COCONU: Get 15% off with promo code: GROWNASS at grownasswoman.guide/coconu 

Let's Connect! The Grown-Ass Woman's Guide is on Facebook and Instagram.

If you like what you hear, consider buying me a coffee!

“Decoding Healthcare” goes on the road to Unity Farm in Sherborn, Mass., to talk with farmer-slash-healthcare visionary John Halamka, M.D., CIO of Beth Israel Deaconness Medical Center in Boston.

In addition to determining exactly why llamas spit, Halamka and podcast hosts athenahealth CMO Kevin Ban, M.D., and athenaInsight editor-in-chief John Fox delve deep on sharing patient records, moving care beyond hospital walls, battling physician burnout, tapping the power of telemedicine, and hooking up with “ambient listening” devices (Alexa, can you hear us?).

You can listen to more episodes of “Decoding Healthcare” on your favorite podcast app, including Apple’s podcast app, Stitcher, and Google Play.
Decoding Healthcare is a production of athenahealth. For more stories and big ideas about healthcare in America today, go to athenaInsight.com. And follow us on Twitter @athenahealth and @KevinBanMD. Thanks for listening!

Value-based payments are built on the idea that money drives behavior. But have the incentives so far been swift and tangible enough to bring about real change? Paul Levy, former CEO of Beth Israel Deaconess Medical Center, offers a reality check about the promise and pace of payment reform, and offers some real suggestions for driving down healthcare costs.

Decoding Healthcare is a production of athenahealth. For more stories and big ideas about healthcare in America today, go to athenaInsight.com. And follow us on Twitter @athenahealth, @JoannaWeiss and @KevinBanMD. Thanks for listening!